Recent News

• 09.04.2025 - Cantor Global Healthcare Conference
• 09.04.2025 - Cantor Global Healthcare Conference
• 09.02.2025 - Editas Medicine Lead In Vivo Development Candidate Webinar
• 09.02.2025 - Editas Medicine Lead In Vivo Development Candidate Webinar
• 09.02.2025 - Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate
• 09.02.2025 - Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate
• 08.28.2025 - Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate
• 08.28.2025 - Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate
• 08.28.2025 - Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate
• 08.27.2025 - Editas Medicine to Participate in Upcoming Investor Conferences

Recent Filings

• 08.29.2025 - 144 Report of proposed sale of securities
• 08.29.2025 - 144 Report of proposed sale of securities
• 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.12.2025 - 8-K Current report
• 08.12.2025 - EX-99.1 EX-99.1
• 08.08.2025 - 4 Statement of changes in beneficial ownership of securities